the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma

NCT05671393 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 801

Last updated 2023-01-04

No results posted yet for this study

Summary

Due to lacking of evidence on surveillance for gastric neuroendocrine carcinoma (G-NEC), this study aimed to determine the optimal postsurgical surveillance strategy for G-NEC patients and compare its cost-effectiveness with traditional surveillance strategies.

Conditions

  • Gastric Neuroendocrine Carcinoma

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Chang-ming Huang, MD · Fujian Medical University Union Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-01
Primary Completion
2016-12-01
Completion
2022-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05671393 on ClinicalTrials.gov